Study Subject Participation Status | Classification Study
Item
patients must be eligible for and enrolled on aall08b1 or the successor classification study
boolean
C2348568 (UMLS CUI [1])
C0008902 (UMLS CUI [2,1])
C2603343 (UMLS CUI [2,2])
Precursor B-cell lymphoblastic leukemia High risk | Precursor B-lymphoblastic leukaemia acute
Item
patients must have newly diagnosed high-risk b lymphoblastic leukemia (world health organization [who] 2008 classification) (also termed b-precursor acute lymphoblastic leukemia)
boolean
C1292769 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C1737235 (UMLS CUI [2])
White Blood Cell Count procedure | Age | Steroid therapy
Item
white blood cell (wbc) >= 50,000/μl for patients age 1-9 or any wbc count for patients age 10-30 or for patients treated with prior steroids
boolean
C0023508 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0149783 (UMLS CUI [3])
Cytotoxic Chemotherapy Absent | Exception Steroids | Exception Cytarabine Intrathecal | Diagnostic procedures on bone marrow | Venous line insertion | Lumbar Puncture second Preventing | CNS status Determination | Systemic Chemotherapy | Intrathecal chemotherapy
Item
patients shall have had no prior cytotoxic chemotherapy with the exception of steroids and intrathecal cytarabine; intrathecal chemotherapy with cytarabine is allowed prior to registration for patient convenience; this is usually done at the time of the diagnostic bone marrow or venous line placement to avoid a second lumbar puncture; (note: the cns status must be determined based on a sample obtained prior to administration of any systemic or intrathecal chemotherapy, except for steroid pretreatment) systemic chemotherapy must begin within 72 hours of this intrathecal therapy
boolean
C0677881 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0038317 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0010711 (UMLS CUI [3,2])
C0677897 (UMLS CUI [3,3])
C0176713 (UMLS CUI [4])
C0398266 (UMLS CUI [5])
C0037943 (UMLS CUI [6,1])
C0205436 (UMLS CUI [6,2])
C1292733 (UMLS CUI [6,3])
C0449389 (UMLS CUI [7,1])
C1148554 (UMLS CUI [7,2])
C1883256 (UMLS CUI [8])
C1517560 (UMLS CUI [9])
Steroid therapy Dosage | Steroid therapy Duration
Item
patients receiving prior steroid therapy are eligible for this study; the dose and duration of previous steroid therapy should be carefully documented
boolean
C0149783 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0149783 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
Menarche Status post Pregnancy test negative
Item
pregnancy tests with a negative result must be obtained in all post-menarchal females
boolean
C0025274 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
C0427780 (UMLS CUI [1,3])
Breast Feeding Absent During Participation Clinical Trial
Item
lactating females must agree that they will not breastfeed a child while on this study
boolean
C0006147 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0679823 (UMLS CUI [1,4])
C0008976 (UMLS CUI [1,5])
Down Syndrome
Item
patients with down syndrome are excluded from this study
boolean
C0013080 (UMLS CUI [1])
testicular leukemia
Item
patients with testicular leukemia at diagnosis are excluded from this study
boolean
C1336711 (UMLS CUI [1])
Pregnancy
Item
pregnant female patients are excluded from this study
boolean
C0032961 (UMLS CUI [1])